Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Hisamitsu Pharmaceutical Co Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - HISAMITSU PHARMACEUTICAL CO INC (4530-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

22 May 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Hisamitsu Pharmaceutical Co Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

12 May 2015 Wright Reports 55 $75.00

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review Summary Hisamitsu Pharmaceutical Co., Inc. (Hisam...

05 May 2015 GlobalData 29 $125.00

Will Hisamitsu Pharmaceutical Co Inc Deliver Long-Term Returns?

12 Mar 2015 Sadif Analytics Prime 11 $25.00

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review Summary Hisamitsu Pharmaceutical Co., Inc. (Hisam...

09 Mar 2015 GlobalData 29 $125.00

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review Summary Hisamitsu Pharmaceutical Co., Inc. (Hisam...

04 Feb 2015 GlobalData 29 $125.00

Will Hisamitsu Pharmaceutical Co Inc Deliver Long-Term Returns?

16 Dec 2014 Sadif Analytics Prime 11 $25.00

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review

Hisamitsu Pharmaceutical Co., Inc. (4530) - Financial Analysis Review Summary Hisamitsu Pharmaceutical Co., Inc. (Hisam...

05 Dec 2014 GlobalData 32 $125.00

Hisamitsu Pharmaceutical Co Inc: Upgraded to Above Average

18 Nov 2014 Sadif Analytics Prime 3 $10.00